rs750935580
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_205836.3(FBXO38):c.561A>G(p.Ile187Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000856 in 1,611,444 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I187T) has been classified as Uncertain significance.
Frequency
Consequence
NM_205836.3 missense
Scores
Clinical Significance
Conservation
Publications
- neuronopathy, distal hereditary motor, type 2DInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- distal hereditary motor neuropathyInheritance: AD Classification: MODERATE Submitted by: ClinGen
- distal hereditary motor neuropathy type 2Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FBXO38 | NM_205836.3 | c.561A>G | p.Ile187Met | missense_variant | Exon 5 of 22 | ENST00000340253.10 | NP_995308.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152132Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000718 AC: 18AN: 250522 AF XY: 0.0000517 show subpopulations
GnomAD4 exome AF: 0.0000870 AC: 127AN: 1459312Hom.: 0 Cov.: 31 AF XY: 0.0000909 AC XY: 66AN XY: 725934 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74338 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Variant summary: FBXO38 c.561A>G (p.Ile187Met) results in a conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. The variant allele was found at a frequency of 7.2e-05 in 250522 control chromosomes. The observed variant frequency is approximately 115 fold of the estimated maximal expected allele frequency for a pathogenic variant in FBXO38 causing Neuronopathy, distal hereditary motor, type 2D phenotype (6.3e-07). To our knowledge, no occurrence of c.561A>G in individuals affected with Neuronopathy, distal hereditary motor, type 2D and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 473960). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Distal hereditary motor neuropathy type 2 Uncertain:1
This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 187 of the FBXO38 protein (p.Ile187Met). This variant is present in population databases (rs750935580, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with FBXO38-related conditions. ClinVar contains an entry for this variant (Variation ID: 473960). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt FBXO38 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at